Ra Medical Systems estimates Q2 2023 revenue of $96,000; H1 2023 revenue $181,000

Catheter Precision, Inc.

Preliminary Q2 2023 revenue estimate of approximately $96,000 (versus $0 prior year quarter, if applicable).
Six-month revenue estimate of approximately $181,000 for H1 2023.
Revenue figures are preliminary and subject to adjustment upon completion of the audit review.
Company filed a Form 12b-25 (NT 10-Q) indicating a delay in its quarterly report.

item 2.02

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Catheter Precision, Inc. reported the six months ended June 30, 2023 results: revenue approximately $181,000.

Period: the six months ended June 30, 2023
Revenue: approximately $181,000
Result: preliminary results

Exact text from the filing

On August 15, 2023, Ra Medical Systems, Inc. (the “Company”) filed a Form 12b-25 with the Securities and Exchange Commission that estimated that the Company will recognize revenues of approximately $96,000 for the quarter ended June 30, 2023 and approximately $181,000 for the six months ended June 30, 2023.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Catheter Precision, Inc. reported the quarter ended June 30, 2023 results: revenue approximately $96,000.

Period: the quarter ended June 30, 2023
Revenue: approximately $96,000
Result: preliminary results

Exact text from the filing

On August 15, 2023, Ra Medical Systems, Inc. (the “Company”) filed a Form 12b-25 with the Securities and Exchange Commission that estimated that the Company will recognize revenues of approximately $96,000 for the quarter ended June 30, 2023 and approximately $181,000 for the six months ended June 30, 2023.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-23-010856

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.